| Stage | ABM | % of rev | PRGS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.3B | 100.00% | $246M | 100.00% | ABM ×9.42 |
| Gross profit | $286M | 12.35% | $204M | 82.74% | PRGS +70.4pp |
| Operating income | $92M | 3.95% | $47M | 18.92% | PRGS +15.0pp |
| Pre-tax income | $63M | 2.73% | $30M | 12.01% | PRGS +9.3pp |
| Net income | $50M | 2.14% | $23M | 9.26% | PRGS +7.1pp |
| Stage | ABM | PRGS | Gap · A − B |
|---|---|---|---|
| Revenue | $2.3B100.00% | $246M100.00% | ABM ×9.42 |
| Gross profit | 12.35%$286M | 82.74%$204M | PRGS +70.4pp |
| Operating income | 3.95%$92M | 18.92%$47M | PRGS +15.0pp |
| Pre-tax income | 2.73%$63M | 12.01%$30M | PRGS +9.3pp |
| Net income |
| 2.14%$50M |
| 9.26%$23M |
| PRGS +7.1pp |
No shared counterparties.